FOLD FY 2016 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$4M83.2% margin

Operating Income

-$182M-3668.6% margin

Net Income

-$200M-4034.7% margin

EPS (Diluted)

$-1.49

Cash Flow

Operating Cash Flow

-$151M

Free Cash Flow

-$156M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$677M

Stockholders' Equity

$360M

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$0	—
Gross Profit	$4M	-$2M	+325.0%
Operating Income	-$182M	-$130M	-39.4%
Net Income	-$200M	-$132M	-51.4%